News
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
20 Jun 24
News, Intraday Update, Markets, Movers, Trading Ideas
Workday To Rally Over 52%? Here Are 10 Top Analyst Forecasts For Thursday
20 Jun 24
News, Price Target, Markets, Analyst Ratings, Trading Ideas
B of A Securities Downgrades Esperion Therapeutics to Underperform, Lowers Price Target to $2.5
20 Jun 24
News, Downgrades, Price Target, Analyst Ratings
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
10 Jun 24
Argan Reports Strong Earnings, Joins Geron, Planet Labs PBC And Other Big Stocks Moving Higher On Friday
7 Jun 24
News, Intraday Update, Markets, Movers, Trading Ideas
HC Wainwright & Co. Reiterates Buy on Esperion Therapeutics, Maintains $16 Price Target
22 May 24
News, Price Target, Reiteration, Analyst Ratings
European Commission Approve NILEMDO And Its Combination With Ezetimibe, NUSTEND For Hypercholesterolemia And Reduce Cardiovascular Risk
22 May 24
Biotech, News, General
HC Wainwright & Co. Reiterates Buy on Esperion Therapeutics, Maintains $16 Price Target
21 May 24
News, Price Target, Reiteration, Analyst Ratings
Esperion Therapeutics/Otsuka Partnered Cholesterol Drug Shows Effective In Japan Study
20 May 24
Biotech, Equities, News, Health Care, Movers, Trading Ideas, General
Esperion, Otsuka Report Primary Endpoint Was Achieved In Phase 3 Trial In Japan For Bempedoic Acid As Potential Treatment For Patients With Hypercholesterolemia
20 May 24
News
HC Wainwright & Co. Reiterates Buy on Esperion Therapeutics, Maintains $16 Price Target
8 May 24
News, Price Target, Reiteration, Analyst Ratings
Needham Reiterates Buy on Esperion Therapeutics, Maintains $8 Price Target
7 May 24
News, Price Target, Reiteration, Analyst Ratings
Heart Disease Drugmaker Esperion Therapeutics Reports Highest Revenue Yet, Stock Soars
7 May 24
Biotech, Earnings, News, Guidance, Health Care, Top Stories, Movers, General
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
7 May 24
Movers
Esperion Therapeutics Q1 EPS $0.34 Beats $0.05 Estimate, Sales $137.74M Beat $84.51M Estimate
7 May 24
Earnings, Earnings Beats, News
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
12 Apr 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
11 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Needham Reiterates Buy on Esperion Therapeutics, Maintains $8 Price Target
10 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
8 Apr 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Reported Sunday, Esperion Presents New Data From CLEAR Outcomes At ACC.24 Highlighting Value Of NEXLETOL® Tablets In Diverse Populations
8 Apr 24
News
Press releases
Esperion to Participate in Upcoming June Investor Conferences
23 May 24
News, Press Releases
Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterolemia
20 May 24
Press Releases
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
10 May 24
Press Releases
Esperion Reports First Quarter 2024 Financial Results
7 May 24
Earnings, Press Releases
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity
7 Apr 24
Press Releases
Actinium Pharmaceuticals (ATNM) Spearheading the Future of Oncology with Iomab-ACT's Innovative Clinical Trial
27 Mar 24
News, Press Releases